Loading
institutionsInstitution
HealthCare Global Enterprises
India's largest private cancer hospital network, with dozens of centres across South Asia and Africa and an early lead in CyberKnife, PET-CT and molecular diagnostics.
Also called: HCGHCG Cancer Centre
Overview
HealthCare Global Enterprises was founded by B.S. Ajaikumar in Bengaluru and grew into the largest specialist cancer chain in India, with a network of comprehensive cancer centres across India plus units in Kenya and elsewhere in Africa. HCG introduced several technologies early to India, including CyberKnife robotic radiosurgery, hospital-based cyclotrons and PET-CT, and its Triesta Sciences and Strand Life Sciences diagnostic arms provide next-generation sequencing, liquid biopsy and molecular pathology. The group runs a sizeable clinical trials business, a bone marrow transplant network and academic training, and publishes on outcomes of cancer care in Indian private practice.
Location
Bengaluru, IN
Type
hospital
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#332 · 20 points (0 Newsweek + 0 NCI + 20 from 10 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-01.
Matched to Healthcare Global Enterprises, including child institutions. 46 works · 54 citations · 72% open access · 17% clinical trials · 4% reviews.
Oncology works per year
122022
32023
92024
142025
82026
Most works
- Radheshyam Naik5 works
- Joseph Mathew4 works
- Vishal U.S. Rao3 works
- Vinod K. Ramani3 works
- Avanish P Saklani3 works
- Shekar Gowda Patil3 works
- K.S. Nataraj3 works
- Jagdish M. Kothari2 works
- Monisha Harimadhavan2 works
- C. T. Satheesh2 works
Most cited
- Cancer hospital network
- Radiosurgery and PET-CT
- Molecular diagnostics (Triesta, Strand)
- Clinical trials
Similar pages
- InstitutionRajiv Gandhi Cancer Institute and Research Centre
Shares SBRT / SABR (stereotactic radiotherapy), Comprehensive genomic profiling, Cervical cancer, Head and neck squamous cell carcinoma.
- PersonMaximilian Diehn
Shares SBRT / SABR (stereotactic radiotherapy), Liquid biopsy (ctDNA), Non-small-cell lung cancer.
- InstitutionShandong Cancer Hospital and Institute
Shares PET/CT, SBRT / SABR (stereotactic radiotherapy), Head and neck squamous cell carcinoma, Non-small-cell lung cancer.
- InstitutionVietnam National Cancer Hospital (K Hospital)
Shares PET/CT, Cervical cancer, Head and neck squamous cell carcinoma, Non-small-cell lung cancer.
- InstitutionKoo Foundation Sun Yat-Sen Cancer Center
Shares SBRT / SABR (stereotactic radiotherapy), Head and neck squamous cell carcinoma, HR-positive / HER2-negative breast cancer, Non-small-cell lung cancer.
- InstitutionHacettepe University Cancer Institute
Shares SBRT / SABR (stereotactic radiotherapy), Cervical cancer, Head and neck squamous cell carcinoma, HR-positive / HER2-negative breast cancer.
- CompanyXcision Medical Systems
Shares SBRT / SABR (stereotactic radiotherapy), HR-positive / HER2-negative breast cancer.
- InstitutionApollo Hospitals (Apollo Cancer Centres)
Shares SBRT / SABR (stereotactic radiotherapy), Head and neck squamous cell carcinoma, HR-positive / HER2-negative breast cancer, Non-small-cell lung cancer.